[go: up one dir, main page]

CL2014002248A1 - Composicion farmaceutica que comprende baba de caracol helix aspersa müller (5% a 50%), extracto de manzanilla (5% a 10%) y miel (5% a 10%); procedimiento de preparacion; uso de la composicion porque sirve para preparar un medicamento o dispositivo util para prevenir o tratar lesiones derivadas de la soriasis. - Google Patents

Composicion farmaceutica que comprende baba de caracol helix aspersa müller (5% a 50%), extracto de manzanilla (5% a 10%) y miel (5% a 10%); procedimiento de preparacion; uso de la composicion porque sirve para preparar un medicamento o dispositivo util para prevenir o tratar lesiones derivadas de la soriasis.

Info

Publication number
CL2014002248A1
CL2014002248A1 CL2014002248A CL2014002248A CL2014002248A1 CL 2014002248 A1 CL2014002248 A1 CL 2014002248A1 CL 2014002248 A CL2014002248 A CL 2014002248A CL 2014002248 A CL2014002248 A CL 2014002248A CL 2014002248 A1 CL2014002248 A1 CL 2014002248A1
Authority
CL
Chile
Prior art keywords
composition
drool
snail
honey
psoriasis
Prior art date
Application number
CL2014002248A
Other languages
English (en)
Inventor
Gonzalez Elmo Moreno
Original Assignee
Muciderm S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Muciderm S A filed Critical Muciderm S A
Priority to CL2014002248A priority Critical patent/CL2014002248A1/es
Priority to US15/501,129 priority patent/US10350247B2/en
Priority to PCT/CL2014/000046 priority patent/WO2016029328A1/es
Publication of CL2014002248A1 publication Critical patent/CL2014002248A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Insects & Arthropods (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Animal Husbandry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CL2014002248A 2014-08-25 2014-08-25 Composicion farmaceutica que comprende baba de caracol helix aspersa müller (5% a 50%), extracto de manzanilla (5% a 10%) y miel (5% a 10%); procedimiento de preparacion; uso de la composicion porque sirve para preparar un medicamento o dispositivo util para prevenir o tratar lesiones derivadas de la soriasis. CL2014002248A1 (es)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CL2014002248A CL2014002248A1 (es) 2014-08-25 2014-08-25 Composicion farmaceutica que comprende baba de caracol helix aspersa müller (5% a 50%), extracto de manzanilla (5% a 10%) y miel (5% a 10%); procedimiento de preparacion; uso de la composicion porque sirve para preparar un medicamento o dispositivo util para prevenir o tratar lesiones derivadas de la soriasis.
US15/501,129 US10350247B2 (en) 2014-08-25 2014-09-12 Pharmaceutical composition for preventing, treating, and curing psoriasis including snail slime, chamomile, and honey
PCT/CL2014/000046 WO2016029328A1 (es) 2014-08-25 2014-09-12 Composición farmacéutica para prevenir, tratar y curar la psoriasis que comprende baba de caracol, manzanilla y miel

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2014002248A CL2014002248A1 (es) 2014-08-25 2014-08-25 Composicion farmaceutica que comprende baba de caracol helix aspersa müller (5% a 50%), extracto de manzanilla (5% a 10%) y miel (5% a 10%); procedimiento de preparacion; uso de la composicion porque sirve para preparar un medicamento o dispositivo util para prevenir o tratar lesiones derivadas de la soriasis.

Publications (1)

Publication Number Publication Date
CL2014002248A1 true CL2014002248A1 (es) 2014-10-17

Family

ID=52002456

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2014002248A CL2014002248A1 (es) 2014-08-25 2014-08-25 Composicion farmaceutica que comprende baba de caracol helix aspersa müller (5% a 50%), extracto de manzanilla (5% a 10%) y miel (5% a 10%); procedimiento de preparacion; uso de la composicion porque sirve para preparar un medicamento o dispositivo util para prevenir o tratar lesiones derivadas de la soriasis.

Country Status (3)

Country Link
US (1) US10350247B2 (es)
CL (1) CL2014002248A1 (es)
WO (1) WO2016029328A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3026108A1 (en) 2016-06-10 2017-12-14 Clarity Cosmetics Inc. Non-comedogenic hair and scalp care formulations and method for use
WO2018117869A1 (en) * 2016-12-23 2018-06-28 Mm Health Ltd Topical formulation comprising green lipped mussel and honey
US10548939B1 (en) * 2018-08-10 2020-02-04 Dr. Cordero Pediatrics Office, Inc. Oat and marigold based composition with anti-inflammatory and wound healing action and method of preparing same
EP3946281A1 (en) 2019-04-02 2022-02-09 Alma Mater Studiorum - Università di Bologna Polymer films comprising material secreted by gastropods
CN111760324B (zh) * 2020-06-28 2022-03-18 张家界继源科技有限公司 一种植物提取装置

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU46889B (sh) 1987-12-23 1994-06-24 Psoricur Ltd. Postupak za dobijanje terapeutskih sastava protiv psorijaze
AU1454592A (en) * 1991-03-01 1992-10-06 Bellavista Enterprises, Inc. Therapeutic and cosmetic compositions for treatment of skin
DE19615293A1 (de) * 1996-04-18 1997-10-23 Johann Dibart Propolis-Hautproblemsalbe - Propolis-Schmerzsalbe
HU227318B1 (en) * 2000-03-08 2011-03-28 Tibor Bodnar Cosmetical and dematological composition for treating, grooming of psoric skin and scalp
WO2009002982A2 (en) 2007-06-23 2008-12-31 Pharmacom International Inc. Gastropod biological fluid, method of making and refining and use
US20100233111A1 (en) * 2008-04-06 2010-09-16 William Wang Gastropod biological fluid, method of making and refining and use
CL2011000143A1 (es) * 2011-01-21 2012-01-06 Muciderm S A Composicion farmaceutica que comprende baba de caracol helix aspersa müller disuelta en una base de crema de cuerpo, extracto natural de calendula y propoleo o aceite de almendras; procedimiento de obtencion de la composicion; y su uso para preparar un medicamento o dispositivo util para prevenir o tratar afecciones tipo ulceras o heridas, tal como ulceras o heridas de pie diabetico.
ES2443816B1 (es) 2012-03-22 2014-12-09 Psoriapiel Salud, S.L. Composición para la prevención y/o el tratamiento de la dermatosis y procedimiento de obtención del mismo

Also Published As

Publication number Publication date
WO2016029328A1 (es) 2016-03-03
US20170216368A1 (en) 2017-08-03
US10350247B2 (en) 2019-07-16

Similar Documents

Publication Publication Date Title
ZA202103074B (en) Formulation based on medicinal plant, or part or extract thereof, use of the formulation and product including said formulation
IL256085B (en) A converted derivative of huanic acid, a pharmaceutical preparation containing it and the converted derivative for use in treatment
PT3383363T (pt) Formulações farmacêuticas tópicas para o tratamento de afeções relacionadas com inflamações
HUE061174T2 (hu) 1,3,4-oxadiazol-szulfonamid-származék vegyületek mint hiszton-deacetiláz-6 inhibitorok, és az ilyen vegyületeket tartalmazó gyógyszerkészímény
IL255203B (en) Topical pharmaceutical emulsion compositions comprising 3,5-dihydroxy-4-isopropyl-trans-stilbene and use thereof in the treatment or prophylaxis of dermatological conditions or disorders
SV2017005461A (es) Benzamidas sustituidas con 1,3-tiazol-2-ilo
MX2021003230A (es) Composiciones farmaceuticas que comprenden meloxicam.
MX2016015093A (es) Derivados de acido boronico y sus usos terapeuticos.
CL2015003690A1 (es) Uso de pridopidina o una sal de la misma para preparar un medicamento útil en el tratamiento de la enfermedad de huntington.
CL2016002072A1 (es) 2-amino-3,5,5-trifluoro-3,4,5,6-tetrahidropiridinas como inhibidores de bace1 para el tratamiento de la enfermedad de alzheimer
BR112015003397A2 (pt) composto, composição farmacêutica, uso do composto e método para tratar uma doença ou condição mediada por rorgammat em um paciente.
CL2016001918A1 (es) Heteroaril amidas como inhibidores de agregación de proteína
EP3009426A4 (en) 4-ALKYNYL-IMIDAZOLE DERIVATIVE AND MEDICAMENT THEREFORE AS AN ACTIVE SUBSTANCE
BR112018005905A2 (pt) ?composto, composição farmacêutica, métodos para evitar ou tratar uma doença ou condição, lesões de órgão, hepatotoxicidade e fígado gorduroso, e, uso de um composto?
MX2016010328A (es) Tratamiento con halogeno de ataque cardiaco y lesion isquemica.
CL2014002248A1 (es) Composicion farmaceutica que comprende baba de caracol helix aspersa müller (5% a 50%), extracto de manzanilla (5% a 10%) y miel (5% a 10%); procedimiento de preparacion; uso de la composicion porque sirve para preparar un medicamento o dispositivo util para prevenir o tratar lesiones derivadas de la soriasis.
WO2015171558A3 (en) BENZENESULFONAMIDO AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORγ AND THE TREATEMENT OF DISEASE
PL3199171T3 (pl) Kompozycja farmaceutyczna do leczenia i zapobiegania degeneracyjnym zaburzeniom neurologicznym, zawierająca, jako składnik aktywny, mieszaninę ekstraktu z kory korzenia piwonii drzewiastej, korzenia dzięgielu dahuryjskiego i korzenia przewiercienia lub ich frakcję
WO2015117841A3 (en) Meta-stable o/w emulsions
EP2956149A4 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HELICOBACTER PYLORI
CL2015001936A1 (es) Composición y su uso que sirve para preparar un medicamento útil para tratar enfermedades relacionadas con el factor inducible por hipoxia (hif).
AR090073A1 (es) N-etil-n-fenil-1,2-dihidro-4,5-di-hidroxi-1-metil-2-oxo-3-quinolinacarboxamida, su preparacion y usos
FR3016289B1 (fr) Extrait vegetal comprenant des sucrose-esters en tant que principe actif et son utilisation dans une composition cosmetique, dermatologique ou nutraceutique
EP3388446A4 (en) IMPROVED ANGIOGENESIS-INHIBITING PEPTIDE AND COMPOSITION FOR THE PREVENTION AND TREATMENT OF ANGIOGENIC DISEASES THEREOF AS AN ACTIVE SUBSTANCE
EP3835311C0 (en) NKX3.2 FRAGMENT AND PHARMACEUTICAL COMPOSITION CONTAINING IT AS ACTIVE INGREDIENT